Other ways to search: Events Calendar | UTHSC

US Biologic® and BARDA DRIVe Partner to Develop Oral Flu Vaccines for Home Delivery


US Biologic today announces a partnership with BARDA DRIVe to develop oral influenza vaccines, increasing access to these life-saving technologies. US Biologic joins DRIVe’s “Beyond the Needle” portfolio of companies developing alternative technologies to transform vaccine administration, making vaccines more widely available and eliminating the need for needles, syringes, vials, and cold-chain distribution burdens.

Top Publishers